GSTA2
GSTA2 (Glutathione S-transferase Alpha 2) is an enzyme that belongs to the glutathione S-transferase (GST) family. These enzymes play a crucial role in the detoxification process by catalyzing the conjugation of the antioxidant glutathione to various endogenous and exogenous compounds. This process helps in the neutralization of toxic substances, making them more water-soluble and easier to excrete from the body.
Structure and Function[edit | edit source]
GSTA2 is one of the several isoenzymes of the alpha class of GSTs. The alpha class is known for its high affinity for glutathione and its role in protecting cells from oxidative stress. The enzyme is primarily found in the liver, but it is also present in other tissues such as the kidney, intestine, and lungs. The primary function of GSTA2 is to detoxify harmful compounds, including carcinogens, drugs, and products of oxidative stress. It achieves this by catalyzing the conjugation of these compounds with glutathione, which facilitates their excretion from the body.
Genetics[edit | edit source]
The gene encoding GSTA2 is located on chromosome 6 in humans. It is part of a cluster of GST genes that includes other alpha class members such as GSTA1, GSTA3, and GSTA4. Variations in the GSTA2 gene can affect the enzyme's activity and have been associated with susceptibility to various diseases, including cancer and cardiovascular diseases.
Clinical Significance[edit | edit source]
Due to its role in detoxification, GSTA2 is of significant interest in the field of pharmacology and toxicology. Variations in GSTA2 expression and activity can influence an individual's response to drugs and susceptibility to toxic substances. For example, lower levels of GSTA2 have been linked to increased risk of liver disease and certain types of cancer.
Research and Applications[edit | edit source]
Research on GSTA2 has focused on understanding its role in disease prevention and treatment. Studies have investigated its potential as a biomarker for liver damage and its involvement in the development of drug resistance in cancer therapy. Additionally, GSTA2 is being explored as a target for new therapeutic interventions aimed at enhancing detoxification processes in the body.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD